Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Jared Bunch

Showing results (271-280 of 330) with videos related to

Pageof 33
Sort By:
The American Journal of Cardiology|May 10, 2017
The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial FibrillationAnjani Golive, Heidi T May, Tami L Bair, et al.
Journal of Cardiovascular Electrophysiology|August 14, 2015
Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long-Term Risk of DementiaVictoria Jacobs, Scott C Woller, Scott M Stevens, et al.
American Heart Journal|June 5, 2017
Atrial fibrillation incrementally increases dementia risk across all CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>VASc strata in patients receiving long-term warfarinKevin G Graves, Heidi T May, Victoria Jacobs, et al.
Journal of Cardiovascular Electrophysiology|October 30, 2020
Patient-reported outcomes and subsequent management in atrial fibrillation clinical practice: Results from the Utah mEVAL AF programBrian Zenger, Mingyuan Zhang, Ann Lyons, et al.
Circulation. Arrhythmia and Electrophysiology|April 17, 2024
Prognostic Impact of Sinus Rhythm in Atrial Fibrillation Patients: Separating Rhythm Outcomes From Randomized Strategy Findings From the CABANA TrialT Jared Bunch, Jeanne E Poole, Adam P Silverstein, et al.
Journal of Cardiovascular Electrophysiology|January 16, 2015
Pulmonary vein isolation for atrial fibrillation in the postpneumonectomy population: a feasibility, safety, and outcomes studyArun Kanmanthareddy, Ajay Vallakati, Madhu Reddy Yeruva, et al.
Journal of Cardiovascular Electrophysiology|May 29, 2009
Warfarin is not needed in low-risk patients following atrial fibrillation ablation proceduresT Jared Bunch, Brian G Crandall, J Peter Weiss, et al.
Pacing and Clinical Electrophysiology : PACE|September 8, 2011
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocksT Jared Bunch, Srijoy Mahapatra, David Murdock, et al.
Heart Rhythm|April 16, 2022
Heart Rhythm Society Atrial Fibrillation Centers of Excellence Study: A survey analysis of stakeholder practices, needs, and barriersRoopinder K Sandhu, Amber Seiler, Colleen J Johnson, et al.
Journal of Cardiovascular Electrophysiology|May 16, 2008
Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathyT Jared Bunch, Thomas M Munger, Paul A Friedman, et al.
Pageof 33

Showing results (271-280 of 330) with videos related to

Sort By:
Pageof 33
The American Journal of Cardiology|May 10, 2017
The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial FibrillationAnjani Golive, Heidi T May, Tami L Bair, et al.
Journal of Cardiovascular Electrophysiology|August 14, 2015
Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long-Term Risk of DementiaVictoria Jacobs, Scott C Woller, Scott M Stevens, et al.
American Heart Journal|June 5, 2017
Atrial fibrillation incrementally increases dementia risk across all CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>VASc strata in patients receiving long-term warfarinKevin G Graves, Heidi T May, Victoria Jacobs, et al.
Journal of Cardiovascular Electrophysiology|October 30, 2020
Patient-reported outcomes and subsequent management in atrial fibrillation clinical practice: Results from the Utah mEVAL AF programBrian Zenger, Mingyuan Zhang, Ann Lyons, et al.
Circulation. Arrhythmia and Electrophysiology|April 17, 2024
Prognostic Impact of Sinus Rhythm in Atrial Fibrillation Patients: Separating Rhythm Outcomes From Randomized Strategy Findings From the CABANA TrialT Jared Bunch, Jeanne E Poole, Adam P Silverstein, et al.
Journal of Cardiovascular Electrophysiology|January 16, 2015
Pulmonary vein isolation for atrial fibrillation in the postpneumonectomy population: a feasibility, safety, and outcomes studyArun Kanmanthareddy, Ajay Vallakati, Madhu Reddy Yeruva, et al.
Journal of Cardiovascular Electrophysiology|May 29, 2009
Warfarin is not needed in low-risk patients following atrial fibrillation ablation proceduresT Jared Bunch, Brian G Crandall, J Peter Weiss, et al.
Pacing and Clinical Electrophysiology : PACE|September 8, 2011
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocksT Jared Bunch, Srijoy Mahapatra, David Murdock, et al.
Heart Rhythm|April 16, 2022
Heart Rhythm Society Atrial Fibrillation Centers of Excellence Study: A survey analysis of stakeholder practices, needs, and barriersRoopinder K Sandhu, Amber Seiler, Colleen J Johnson, et al.
Journal of Cardiovascular Electrophysiology|May 16, 2008
Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathyT Jared Bunch, Thomas M Munger, Paul A Friedman, et al.
Pageof 33